Background: Appropriate levels of skeletal muscle tone are needed to support routine motor behaviors. But, the brain mechanisms that function to couple muscle tone with waking behaviors are unknown. We addressed this question by studying mice with cataplexy-a condition caused by a decoupling of motor and arousal behaviors. Cataplexy is characterized by involuntary loss of muscle tone during wakefulness, which results in postural collapse during otherwise normal consciousness. Cataplexy is caused by loss of hypocretin (orexin) cells, but it is unknown how this loss triggers motor inactivity during cataplexy. Here, we used hypocretin knockout mice to identify the neurochemical cause of cataplexy and to determine the biochemical mechanisms that normally function to couple arousal and motor systems. Results: Using genetic, behavioral, electrophysiological, and pharmacological approaches, we show that the noradrenergic system acts to synchronize motor and arousal systems. Specifically, we show that an excitatory noradrenergic drive maintains postural muscle tone during wakefulness by activating a 1 receptors on skeletal motoneurons. Loss of this normal excitatory drive triggers motor inactivity during cataplexy by reducing motoneuron excitation. However, loss of this drive does not affect arousal since mice remain awake during cataplexy, suggesting the noradrenergic system is not required for maintaining wakefulness. Artificial restoration of noradrenergic drive to motoneurons prevents motor inactivity and rescues cataplexy. Conclusions: We conclude that hypocretin deficiency causes cataplexy by short-circuiting the noradrenergic drive to skeletal motoneurons. We suggest that the noradrenergic system functions to couple the brain systems that control postural muscle tone and behavioral arousal state.
Introduction
A generalized level of postural muscle tone is required to support waking behaviors. During active wakefulness, high levels of muscle tone function to maintain routine body postures such as sitting or standing. The importance of postural tone becomes immediately apparent as soon as it is lost. Becoming ''weak with laughter'' or ''weak at the knees'' are common expressions that illustrate the impact of muscle tone on normal behaviors. Despite its importance, the mechanisms that function to match postural muscle tone with wakefulness remain undetermined.
Under rare conditions, arousal state and motor activity decouple. Opossums will voluntarily immobilize themselves to escape predation. While ''playing dead,'' they are functionally paralyzed but behaviorally alert [1] . A similar but involuntary phenomenon known as cataplexy occurs in humans. During cataplexy, muscle paralysis (atonia) overwhelms the skeletal motor system, leaving the affected individual awake but either fully or partially immobilized [2] [3] [4] . Cataplexy is therefore a useful experimental model for understanding how the central nervous system (CNS) couples motor activity and behavior state. Although cataplexy results from loss of hypocretin cells, it is unclear how this causes cataplexy.
The noradrenergic system is thought to play an important role in coupling muscle tone with behavioral state. Noradrenergic cells project to brain structures that mediate both behaviors, and their direct stimulation can facilitate muscle tone and arousal state [5] [6] [7] [8] . Noradrenergic cells also discharge in a pattern that implies they synchronize these behaviors. Locus coeruleus (LC) cells fire maximally during waking, when postural tone is highest, and minimally during sleep when it is lowest [4, 9] . However, a landmark study found that noradrenergic cells stop firing during cataplexy when consciousness is preserved but motor tone is minimal [4] . These observations sparked the long-standing-but untested-hypothesis that noradrenergic system inactivity causes cataplexy.
We used a mouse model of cataplexy [10, 11] to determine whether loss of noradrenergic drive is its root cause. First, we found that cataplexy attacks are sensitive to changes in noradrenergic system activity. We showed that increased noradrenergic drive prevents cataplexy, whereas decreased drive exacerbates it. Second, we demonstrate that cataplexy is caused by loss of noradrenergic drive to motoneuronsi.e., the cells that directly support muscle tone. During normal wakefulness, noradrenergic drive supports postural tone by activating a 1 receptors on motoneurons. But, during cataplexy, this excitatory drive is lost, in turn triggering motor paralysis by reducing a 1 -receptor-driven motoneuron activation. Finally, we show that restoration of noradrenergic drive to motoneurons rescues muscle paralysis during cataplexy. We conclude that cataplexy is caused by loss of the noradrenergic drive that functions to promote waking muscle tone. The noradrenergic system therefore functions to ensure that postural muscle tone is appropriately matched to arousal state.
Results

Cataplexy Results from Decoupling of Motor and Arousal Systems
Cataplexy is a chief symptom of narcolepsy-a sleep disorder marked by abnormal rapid eye movement (REM) sleep control [3] . Genetic deletion of the hypocretin gene (hypocretin knockout mice) causes a behavioral phenotype that mimics human narcolepsy, including episodes of cataplexy. Here, we used hypocretin knockout mice to determine whether changes in noradrenergic system function are responsible, either in whole or part, for triggering cataplexy.
We used both behavioral and electrophysiological criteria to characterize and identify cataplexy episodes and typical sleep-wake states. Narcoleptic mice (n = 8) experienced multiple episodes of cataplexy during the recording period (i.e., *Correspondence: john.peever@utoronto.ca 19:00 hr-01:00 hr). Cataplexy occurred exclusively during active wakefulness and was characterized by abrupt behavioral arrest and postural collapse (Movie S1 available online). During each episode, electromyographic (EMG) tone decreased while electroencephalographic (EEG) activity remained wake-like in nature. Power spectral analysis indicates that EEG activity during cataplexy is comparable to wakefulness, suggesting that cortical arousal (i.e., consciousness) is maintained during such attacks, as it is in humans [10, 11] . Cataplexy is terminated quickly ( Figures 1A and 1C) , with mice resuming typical waking behaviors such as grooming, eating, or walking. During the 6 hr recording period, narcoleptic mice experienced 3 6 1 cataplexy episodes that each lasted 66 6 15 s.
Cataplexy may result from the intrusion of REM sleep paralysis (atonia) into waking [3] . However, it is unknown whether postural muscles become atonic or simply experience reduced tone during cataplexy. We quantified both masseter and neck muscle tone during cataplexy and REM sleep paralysis ( Figure 1B ) and found that EMG tone rapidly decreased at cataplexy onset and returned at cataplexy offset (n = 8; before cataplexy versus during cataplexy: H = 16.22, p < 0.01 for both neck and masseter muscles; Figure 1C ). During cataplexy, both masseter and neck muscle tone remained at levels comparable to those experienced during REM sleep paralysis (REM versus cataplexy: masseter, t = 0.497, df = 12, p = 0.663, neck, t = 72.0, p = 0.202; Figures 1B-1D ).
These findings illustrate that during cataplexy narcoleptic mice-like narcoleptic humans-experience REM-like motor paralysis in masseter (and neck) muscles despite maintained wakefulness. Experimentally, this means that we can use the trigeminal motoneurons, as well as the masseter muscles they innervate, as a model system for determining how motoneurons are switched off during cataplexy.
Noradrenergic System Activity Influences Cataplexy A first step in linking noradrenergic system function with control of cataplexy is to demonstrate that cataplexy expression is affected by changes in noradrenergic activity. Noradrenergic receptor manipulation has been previously shown to influence cataplexy in dogs with hypocretin-2 receptor mutations and in humans with hypocretin cell loss [12, 13] . But, it is unknown whether such changes also modulate cataplexy expression in hypocretin knockout mice. To test the hypothesis that cataplexy is triggered by a noradrenergic mechanism, we injected different doses of either an a 1 receptor agonist (5 and 10 mg/kg phenylephrine; intraperitoneal) or antagonist (5 and 10 mg/kg terazosin; intraperitoneal).
We found that agonism of a 1 receptors reduced amounts of cataplexy. Even though a 5 mg/kg dose of phenylephrine reduced the total amount of cataplexy by 73% and reduced the number of episodes by 67%, these reductions were not statistically significant (n = 6; p > 0.05 for both variables; Figures 2A and 2B ). However, 10 mg/kg phenylephrine reduced amounts of cataplexy by 90% (n = 6; H = 9.095, df = 2, p < 0.05; Figure 2A ). This decrease was caused by a 92% reduction in the number of cataplectic episodes (F = 6.2, df = 2, p = 0.01, Figure 2B) ; the duration of individual episodes of cataplexy was not affected by this intervention (p > 0.05; data not shown). These findings demonstrate that a 1 receptor stimulation prevents cataplexy attacks and support the hypothesis that cataplexy is mediated by a noradrenergic mechanism.
Next, we found that a 1 receptor antagonism increased cataplexy. A 5 mg/kg dose of terazosin had no effect on either the number or duration of cataplectic episodes (n = 6; right masseter ANOVA, p > 0.05 for both variables; Figure 2D ). But, a single injection of 10 mg/kg terazosin increased the number of cataplectic episodes by 92% (n = 6; right masseter ANOVA, F = 7.75, df = 2, p < 0.05; Figure 2D ) despite having no significant effect on the total amount of time spent in cataplexy (p > 0.05; Figure 2C ) or episode duration (p > 0.05; data not shown). 
Noradrenergic Drive to Motoneurons Is Lost during Cataplexy
Since LC neurons stop firing during cataplexy in narcoleptic dogs, it has been hypothesized that loss of noradrenergic drive to motoneurons underlies cataplexy [4, 14] . Therefore, we aimed to determine (1) whether an endogenous noradrenergic drive at the trigeminal motor pool functions to support postural muscle tone during normal wakefulness and (2) whether loss of this excitatory drive to motoneurons is responsible for triggering cataplexy in narcoleptic mice.
First, we identified the presence of a functional noradrenergic drive onto trigeminal motoneurons that acts to support waking muscle tone. We found that antagonism of a 1 adrenergic receptors by terazosin perfusion (1 mM) at the left trigeminal motor pool markedly suppressed left masseter muscle tone during waking (artificial cerebrospinal fluid [aCSF] versus terazosin: t = 4.47, df = 3, p = 0.03). Specifically, we showed that receptor antagonism reduced waking masseter tone by 33% in the 30 s period before cataplexy and by 31% in the 30 s period after cataplexy (before cataplexy: Z = 22.71, p < 0.01; after cataplexy: Z = 21.98, p = 0.053; Figure 3A ). This finding provides direct support for the idea that high noradrenergic drive to motoneurons supports waking levels of postural tone. Importantly, applied drugs targeted the left trigeminal motor nucleus ( Figure S2 ) and had minimal effects of sleepwake architecture ( Figure S3 ).
Drug manipulations were specifically targeted at motoneurons in the left trigeminal motor pool since right masseter muscle activity (before cataplexy: p > 0.05; after cataplexy: p > 0.05; Figure 3B ) was unaffected by these manipulations. These findings therefore suggest that suppression of waking (left) masseter tone was the result of direct motoneuron manipulation and did not result from nonspecific manipulation of the trigeminal interneurons that encapsulate the motor pool [15] .
Second, we showed that noradrenergic drive onto trigeminal motoneurons is lost during cataplexy episodes. Although a 1 adrenergic receptor antagonism significantly reduced left masseter tone during periods of waking immediately preceding and following cataplectic attacks, this same intervention had no effect on masseter muscle tone during discrete cataplexy episodes (aCSF versus terazosin: Z = 20.365, p > 0.05; Figure 3A ). This observation suggests that noradrenergic excitation of motoneurons is either minimal or absent during cataplexy and is consistent with unit recording studies showing that noradrenergic cell activity is absent during periods of cataplexy [4] .
Although we found that a 1 receptor blockade at the trigeminal motor pool reduced masseter muscle tone during normal waking, it did not reduce tone to the same levels that occurred during cataplexy (terazosin wake versus cataplexy: F = 30, df = 2, p = 0.020; Figure 3C ). Together, these findings indicate that a functional noradrenergic drive maintains waking levels of postural muscle tone; however, it is unlikely that loss of this drive is the only mechanism responsible for muscle paralysis during cataplexy (see the Discussion).
Restoration of Noradrenergic Drive Rescues Muscle Paralysis during Cataplexy
Our final goal was to determine whether muscle atonia during cataplexy could be prevented by restoration of noradrenergic drive onto motoneurons. However, we first wanted to determine whether activation of a 1 receptors on motoneurons could prevent the natural loss of masseter muscle tone during sleep. To do this, we applied the a 1 receptor agonist 1 mM phenylephrine into the trigeminal motor nucleus during non-REM and REM sleep in both wild-type and narcoleptic mice. We found that phenylephrine perfusion prevented the normal loss of masseter muscle tone during sleep by increasing muscle tone by 13% 6 4% during non-REM sleep (n = 9; aCSF versus phenylephrine: t = 23.83, p = 0.006) and by 12% 6 3% during REM sleep in wild-type mice (t = 23.13, p < 0.05; Figures 4A and 4B ). This same intervention increased masseter tone by 30% 6 5% during non-REM (n = 10; aCSF versus phenylephrine: t = 24.56, p = 0.001) sleep and by 35% 6 9% during REM sleep (t = 23.40, p = 0.008; Figures  4C and 4D ) in narcoleptic mice. These results demonstrate that muscle tone can be restored with an exogenous noradrenergic drive to motoneurons.
To determine whether loss of noradrenergic drive underlies muscle atonia during cataplexy, we pharmacologically A B C Figure 3 . Loss of Noradrenergic Drive Contributes to Muscle Atonia during Cataplexy (A) Waking levels of left masseter muscle tone are significantly reduced by a 1 receptor antagonism (terazosin) at the left trigeminal motor pool. However, this same intervention had no effect on masseter muscle tone during cataplexy, demonstrating that the waking noradrenergic drive is withdrawn during cataplexy. (B) a 1 receptor manipulation at the left trigeminal motor pool affected left masseter muscle tone but has no impact on right masseter muscle tone. (C) Antagonism of a 1 receptors on trigeminal motor neurons (by terazosin perfusion) reduced waking masseter muscle tone, but it did not lower it to cataplectic levels, indicating that loss of noradrenergic drive is not the only mechanism triggering muscle atonia during cataplexy. *p < 0.05. A.U., arbitrary units. Values are plotted as means + SEM. See also Figure S1 , which shows that drug manipulations primarily target motoneurons in the left trigeminal motor pool. restored this excitatory drive to motoneurons during cataplexy. We found that activation of a 1 receptors at the left trigeminal motor pool increased left masseter tone during cataplexy (aCSF versus phenylephrine: t test, t = 24.20 p < 0.01; Figures 5A and 5B) . Specifically, we found that receptor activation increased masseter tone by 93% 6 33% above baseline cataplexy levels. Phenylephrine perfusion increased left masseter muscle tone during cataplexy to levels similar to those seen during normal waking (cataplexy aCSF versus cataplexy phenylephrine: ANOVA on ranks, p > 0.05; Figure 5C ). However, this targeted intervention had no effect on either right masseter (p > 0.05; Figure 5B ) or neck (p > 0.05; data not shown) muscle tone. Muscle atonia in both muscle groups remained intact during cataplexy, illustrating that drug manipulation primarily influenced motoneurons in the targeted motor pool.
Discussion
Postural muscle tone is needed to support routine motor behaviors. Despite its obvious behavioral importance, it was unknown how postural muscle tone and brain arousal state are functionally coupled. Here, we demonstrate that the noradrenergic system acts to synchronize motor and arousal systems by facilitating skeletal motoneuron activity and hence muscle tone during wakefulness. Loss of this normal excitatory drive decouples these systems, thus resulting in motor atonia during otherwise normal wakefulness, as is seen in cataplexy. Our data suggest that loss of hypocretin could trigger motor atonia by influencing noradrenergic system function.
The Noradrenergic System Functions to Promote Waking Postural Motor Tone
The noradrenergic system has long been considered important in controlling muscle tone. Stimulation of brainstem noradrenergic cells (e.g., LC cells) in anaesthetized or decerebrate animals can facilitate motoneuron activity by a a 1 -receptor-mediated mechanism [6, 7, [16] [17] [18] . Although this shows the noradrenergic system modulates muscle tone, it does not demonstrate that it promotes motor activity during actual behaviors. Support for this view comes from unit recording studies showing that noradrenergic cell activity is tightly correlated to levels of muscle tone; e.g., locus coeruleus cells fire maximally when muscle tone is high and minimally when it is showing that phenylephrine perfusion also increased masseter muscle tone during non-REM and REM sleep in narcoleptic mice. These results show that 1 mM phenylephrine has the ability to rescue muscle tone during sleep in both wild-type and narcoleptic mice. This concentration should therefore be able to restore muscle tone during cataplexy. *p < 0.05. A.U., arbitrary units. Values are plotted as means + SEM. low [9] . These studies are clouded by the fact that cell discharge rates also correlate with arousal state, thus making it difficult to determine whether their activity reflects levels of muscle tone, behavioral state, or both. Perhaps the strongest evidence suggesting that a noradrenergic mechanism underlies postural tone stems from quantitative studies showing that levels of noradrenaline within spinal/cranial motor pools is broadly proportional to levels of muscle tone [19] . Noradrenaline may excite motoneurons by a direct a1-receptor-mediated mechanism or by facilitating persistent inward currents or potentially by amplifying glutamatergic drive onto motoneurons [20, 21] .
Our current data show that postural muscle tone is indeed controlled by a noradrenergic mechanism during wakefulness. Specifically, we show that a functional noradrenergic drive triggers postural muscle tone by stimulating a 1 receptors on motoneurons. A similar type of noradrenergic mechanism has been previously shown to underlie more specialized motor behaviors: a noradrenergic drive acting on respiratory motoneurons is responsible for regulating the so-called ''wakefulness stimulus to breathe'' [7] , and loss of this drive is thought to underlie reduced respiratory muscle activity during REMlike sleep [16] . Collectively, these data show the noradrenergic system is pivotal in controlling levels of muscle tone in different motor systems.
Loss of Noradrenergic Drive Underlies Cataplexy
A longstanding hypothesis is that cataplexy is triggered by loss of noradrenergic system activity, but direct evidence for this idea was lacking [4, 14] . Here, we show that withdrawal of a functional noradrenergic drive to trigeminal motoneurons underlies masseter muscle paralysis during cataplexy. This excitatory drive is present during the waking periods immediately before and after cataplexy but is rapidly withdrawn during cataplectic attacks.
Our data are consistent with studies in narcoleptic dogs showing that cell activity in the LC is correlated with cataplexy [4, 14] . Unit recordings show that cell activity is maximal immediately before and after cataplectic attacks but falls silent during attacks, suggesting that noradrenergic system inactivity triggers motor atonia during cataplexy. Our data provide support for this observation by showing that noradrenergic drive to motoneurons is either lost or minimal during cataplexy in narcoleptic mice.
It is debatable whether LC cell inactivity itself causes motor paralysis during cataplexy. Although these cells stop firing during cataplexy, they send relatively few direct projections to skeletal motoneurons [22] . Other sources of noradrenergic drive to motoneurons could be from A5 and/or A7 cell groups [22, 23] . It is unknown whether inactivity of these cells promote cataplexy, but A5 cells stop firing during REM-like sleep [24, 25] , suggesting that their inactivity promotes muscle atonia.
A noradrenergic mechanism is not uniquely responsible for triggering cataplexy. We found that antagonization of a 1 receptors on motoneurons markedly suppressed postural tone, but it did not induce complete motor paralysis, indicating that additional mechanisms are involved. Unit recordings from brainstem cells show that serotonin cell activity is reduced and GABA/glycine cell activity is increased during cataplexy in narcoleptic dogs [26, 27] . This observation implies that reduced serotonin excitation and increased GABA/glycine inhibition could also contribute to loss of motor tone during cataplexy.
Increasing Noradrenergic Drive Rescues Cataplexy
Drugs that boost noradrenergic system activity are used to treat cataplexy. Tricyclic antidepressants-which elevate CNS levels of noradrenaline-are effective in reducing cataplexy in narcoleptic people, dogs, and mice [12, [28] [29] [30] [31] [32] [33] . Although tricyclics influence a variety of transmitter systems (e.g., serotonin), they are thought to mediate their affects on cataplexy by a noradrenergic mechanism [34] . Pharmacological studies show that selective noradrenergic receptor manipulation effects cataplexy in narcoleptic dogs [12, 34, 35] .
Our data indicate that cataplexy results from functional loss of noradrenergic drive. We therefore hypothesize that tricyclic antidepressants and noradrenergic reuptake inhibitors may exert their actions by restoring this drive. Specifically, we suggest that they act to increase noradrenaline, which functions to protect motoneurons from the drop in noradrenergic drive during cataplexy. Our pharmacological studies show that boosting noradrenergic drive prevents cataplexy, whereas decreasing drive exacerbates it. But, more importantly, we show that direct restoration of noradrenergic drive to motoneurons prevents motor paralysis during cataplexy. Both of these findings support our assertion that (1) cataplexy results from loss of noradrenergic drive and (2) that rescue of this lost drive prevents cataplexy.
Hypocretin Deficiency Impacts Noradrenergic System Function Hypocretin deficiency underlies cataplexy since hypocretin cell loss, inability to produce hypocretin, and dysfunctional hypocretin receptors can trigger cataplexy in humans, dogs, rats, and mice [10, 11, [36] [37] [38] [39] [40] . However, it is unclear how hypocretin system dysfunction causes cataplexy. Our work suggests that hypocretin deficiency could trigger cataplexy by disrupting normal noradrenergic system function.
There are strong connections between the hypocretin and noradrenergic systems. For example, hypocretin cells send dense projects to noradrenergic cells, and particularly those in the LC. Noradrenergic cells also express hypocretin receptors and are markedly excited by hypocretin application. Furthermore, hypocretin levels in the LC influence noradrenergic release onto target sites [41] . Together, these findings suggest that noradrenergic activity is tightly controlled by the hypocretin system.
Our data indicate that a faulty noradrenergic signaling mechanism underlies cataplexy in hypocretin knockout mice, suggesting that hypocretin deficiency perturbs normal noradrenergic system function. We propose that waking postural muscle tone is supported by the combined actions of hypocretin and noradrenergic system activity ( Figures 6A and 6B) . In healthy people, hypocretin facilitates postural tone directly and by driving noradrenergic release onto motoneurons. But in narcolepsy, hypocretin drive is lost, which reduces noradrenergic activity and hence excitation of skeletal motoneurons, thus resulting in cataplexy ( Figure 6C) .
But, why is cataplexy generally triggered by strong positive emotions or rewarding stimuli? The hypocretin system is most active during situations normally associated with cataplexy in narcoleptics. For example, hypocretin release is maximal during social interactions in nonnarcoleptic humans [42] , and hypocretin cell activity is highest during novel conditions in rats [43] . Therefore, hypocretin deficiency would be expected to tip the normal balance of noradrenergic excitation during situations associated with cataplexy, thus leading to lapses in noradrenergic drive to motoneurons and hence cataplexy.
The Noradrenergic System Functions to Couple Motor and Arousal Systems
This study provides a new framework for understanding how the noradrenergic system controls normal physiology and behavior. First, it shows that one of its functions is to control levels of postural motor tone during wakefulness. Second, it shows that loss of noradrenergic system activity results in motor atonia during otherwise normal wakefulness (i.e., cataplexy). Together, these observations indicate that the noradrenergic system functions to synchronize motor and arousal behaviors.
The noradrenergic system has been hypothesized to control behavioral arousal state. For example, optogenetic activation of noradrenergic cells in the LC can stimulate behavioral arousal from sleep [44] . However, some studies have questioned the role of the noradrenergic system in mediating arousal. Unit recording studies in narcoleptic dogs show that during cataplexy LC cells stop firing, but tuberomamillary histaminergic neurons do not [14] . This suggests that the histaminergic system is primarily responsible for promoting arousal, whereas the noradrenergic system functions to support postural muscle tone; although other transmitter systems are also involved in both arousal and muscle tone.
Recent optogenetic studies also support our assertion that the noradrenergic system acts to synchronize motor and arousal behaviors. Overstimulation of the LC caused depletion of their noradrenergic stores and hence release, which led to rapid onset of behavioral arrests in wild-type mice [44] . These arrests were similar to the cataplexy attacks because they were marked by postural collapse during wakefulness. These findings not only support our view that cataplexy results from reduced noradrenergic drive to motoneurons, but also suggest that the noradrenergic system functions to couple motor behavior with arousal state.
Experimental Procedures
All studies were carried out in accordance with the Canadian Council on Animal Care and approved by the Animal Care Committee at the University of Toronto. Previously described protocols were used for (1) instrumentation of mice with electrophysiological electrodes for sleep-wake behaviors and cataplexy [45, 46] and (2) selective application of transmitter agonists or antagonists to target brain regions [47, 48] . A complete description of these and other materials and methods are available in the Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures, two figures, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.cub.2013.07.014. Under normal waking conditions, hypocretin neurons (Hcrt) are active, providing excitatory inputs to noradrenergic (NA) and histaminergic (HA) neurons; this in turn helps maintain both waking muscle tone and arousal. During sleep, while both arousal and muscle tone are low, all three cell groups fall silent. During cataplexy, muscle tone is absent, but arousal and consciousness are intact. This decoupling of arousal state and appropriate levels of muscle tone is mirrored by the continued activity of histamine neurons while noradrenaline neurons fall silent, suggesting that the noradrenergic system acts to facilitate normal waking muscle tone while histamine acts to support consciousness. Noradrenergic excitation of muscle tone could be via direct excitation of spinal motor neurons (from A5, the LC, and A7) or indirect through brainstem circuits that regulate muscle tone. This schematic does not include several nuclei that have been demonstrated to play a role in muscle tone or cortical arousal, including cholinergic, dopaminergic, and serotonergic nuclei, but demonstrates how these behaviors can be decoupled under specific conditions such as cataplexy.
